The Social Determinants of Health Screening and Referral Project
Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · Aug 29, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The Social Determinants of Health Screening and Referral Project is a study aimed at understanding how social factors, like housing and job security, impact families with preterm infants. Many families face challenges that can affect their health and the health of their babies. This trial seeks to take a successful method of checking for these social needs and providing support, which has worked in outpatient settings, and apply it in the Neonatal Intensive Care Unit (NICU). By doing this, the study hopes to help mothers and their preterm infants by connecting them with resources that can improve their overall well-being.
To participate in this trial, mothers and their infants need to meet certain criteria. Eligible infants must be born before 34 weeks of pregnancy and have spent at least 14 days in the NICU. The mother should be able to speak and read either English or Spanish and plan to care for her baby at home in the U.S. for at least a year after leaving the hospital. The study is not yet recruiting participants, but if you qualify, you can expect to receive support based on your family's unique social needs, which can help you and your baby thrive after discharge from the NICU.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Infant gestational age \<34 weeks' gestation; singleton or multiple.
- • Infant hospitalized for at least 14 days of life (to allow for SDOH screening/referral and contact with resources if applicable).
- • Mother and infant are alive.
- • Mother speaks and reads English or Spanish.
- • Infant will be discharged home from the NICU (to allow for follow-up).
- • Mother will care for her infant(s) at home in the US for at least 12 months after discharge from the NICU.
- Exclusion Criteria:
- • Mothers or infants who die before anticipated infant discharge.
- • Infant discharged after 52 weeks postmenstrual age.
About University Of Massachusetts, Worcester
The University of Massachusetts Worcester is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the university integrates cutting-edge scientific inquiry with a commitment to improving patient outcomes. Its collaborative approach engages a diverse range of experts, fostering interdisciplinary research that addresses pressing health challenges. With a focus on ethical standards and regulatory compliance, the University of Massachusetts Worcester plays a pivotal role in translating scientific discoveries into practical applications that enhance medical practice and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Detroit, Michigan, United States
Jackson, Mississippi, United States
Philadelphia, Pennsylvania, United States
Cincinnati, Ohio, United States
Bronx, New York, United States
Denver, Colorado, United States
Jacksonville, Florida, United States
Patients applied
Trial Officials
Margaret Parker, MD, MPH
Principal Investigator
University of Massachusetts Chan Medical School
Mari-Lynn Drainoni, PhD, MEd
Principal Investigator
Boston University Chobanian and Avedisian School of Medicine
Arvin Garg, MD, MPH
Principal Investigator
University of Massachusetts Chan Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported